Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Receivables - Net (2016 - 2025)

Historic Receivables - Net for HUTCHMED (China) (HCM) over the last 12 years, with Q2 2025 value amounting to $147.0 million.

  • HUTCHMED (China)'s Receivables - Net fell 634.03% to $147.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $147.0 million, marking a year-over-year decrease of 634.03%. This contributed to the annual value of -$38.5 million for FY2024, which is 28065.71% down from last year.
  • Latest data reveals that HUTCHMED (China) reported Receivables - Net of $147.0 million as of Q2 2025, which was down 634.03% from $20.0 billion recorded in Q4 2024.
  • HUTCHMED (China)'s 5-year Receivables - Net high stood at $20.0 billion for Q4 2024, and its period low was -$35.6 million during Q4 2021.
  • Its 5-year average for Receivables - Net is $3.6 billion, with a median of $103.1 million in 2022.
  • As far as peak fluctuations go, HUTCHMED (China)'s Receivables - Net plummeted by 65930.11% in 2021, and later skyrocketed by 11932703.25% in 2023.
  • Quarter analysis of 5 years shows HUTCHMED (China)'s Receivables - Net stood at -$35.6 million in 2021, then skyrocketed by 135.15% to $12.5 million in 2022, then soared by 119327.03% to $15.0 billion in 2023, then soared by 33.73% to $20.0 billion in 2024, then crashed by 99.27% to $147.0 million in 2025.
  • Its last three reported values are $147.0 million in Q2 2025, $20.0 billion for Q4 2024, and $156.9 million during Q2 2024.